18-12348286-T-C

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_006796.3(AFG3L2):​c.1650A>G​(p.Glu550Glu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.774 in 1,612,264 control chromosomes in the GnomAD database, including 486,115 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.76 ( 44628 hom., cov: 32)
Exomes 𝑓: 0.78 ( 441487 hom. )

Consequence

AFG3L2
NM_006796.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:12

Conservation

PhyloP100: -0.278

Publications

23 publications found
Variant links:
Genes affected
AFG3L2 (HGNC:315): (AFG3 like matrix AAA peptidase subunit 2) This gene encodes a protein localized in mitochondria and closely related to paraplegin. The paraplegin gene is responsible for an autosomal recessive form of hereditary spastic paraplegia. This gene is a candidate gene for other hereditary spastic paraplegias or neurodegenerative disorders. [provided by RefSeq, Jul 2008]
AFG3L2 Gene-Disease associations (from GenCC):
  • spinocerebellar ataxia type 28
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Illumina, Genomics England PanelApp
  • spastic ataxia 5
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet, Labcorp Genetics (formerly Invitae), G2P
  • optic atrophy 12
    Inheritance: AD Classification: STRONG Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.54).
BP6
Variant 18-12348286-T-C is Benign according to our data. Variant chr18-12348286-T-C is described in ClinVar as Benign. ClinVar VariationId is 128287.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.278 with no splicing effect.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.779 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
AFG3L2NM_006796.3 linkc.1650A>G p.Glu550Glu synonymous_variant Exon 13 of 17 ENST00000269143.8 NP_006787.2
AFG3L2XM_011525601.4 linkc.1650A>G p.Glu550Glu synonymous_variant Exon 13 of 16 XP_011523903.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
AFG3L2ENST00000269143.8 linkc.1650A>G p.Glu550Glu synonymous_variant Exon 13 of 17 1 NM_006796.3 ENSP00000269143.2

Frequencies

GnomAD3 genomes
AF:
0.764
AC:
116068
AN:
151996
Hom.:
44587
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.768
Gnomad AMI
AF:
0.765
Gnomad AMR
AF:
0.652
Gnomad ASJ
AF:
0.754
Gnomad EAS
AF:
0.620
Gnomad SAS
AF:
0.781
Gnomad FIN
AF:
0.844
Gnomad MID
AF:
0.741
Gnomad NFE
AF:
0.784
Gnomad OTH
AF:
0.750
GnomAD2 exomes
AF:
0.741
AC:
186247
AN:
251364
AF XY:
0.748
show subpopulations
Gnomad AFR exome
AF:
0.764
Gnomad AMR exome
AF:
0.568
Gnomad ASJ exome
AF:
0.753
Gnomad EAS exome
AF:
0.611
Gnomad FIN exome
AF:
0.835
Gnomad NFE exome
AF:
0.781
Gnomad OTH exome
AF:
0.742
GnomAD4 exome
AF:
0.776
AC:
1132511
AN:
1460150
Hom.:
441487
Cov.:
38
AF XY:
0.776
AC XY:
563587
AN XY:
726486
show subpopulations
African (AFR)
AF:
0.771
AC:
25777
AN:
33442
American (AMR)
AF:
0.580
AC:
25917
AN:
44718
Ashkenazi Jewish (ASJ)
AF:
0.759
AC:
19832
AN:
26112
East Asian (EAS)
AF:
0.602
AC:
23888
AN:
39684
South Asian (SAS)
AF:
0.785
AC:
67703
AN:
86226
European-Finnish (FIN)
AF:
0.831
AC:
44393
AN:
53412
Middle Eastern (MID)
AF:
0.769
AC:
4435
AN:
5764
European-Non Finnish (NFE)
AF:
0.787
AC:
874269
AN:
1110450
Other (OTH)
AF:
0.767
AC:
46297
AN:
60342
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.461
Heterozygous variant carriers
0
12482
24965
37447
49930
62412
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20578
41156
61734
82312
102890
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.764
AC:
116161
AN:
152114
Hom.:
44628
Cov.:
32
AF XY:
0.763
AC XY:
56773
AN XY:
74364
show subpopulations
African (AFR)
AF:
0.768
AC:
31848
AN:
41470
American (AMR)
AF:
0.652
AC:
9962
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.754
AC:
2614
AN:
3468
East Asian (EAS)
AF:
0.621
AC:
3208
AN:
5164
South Asian (SAS)
AF:
0.781
AC:
3759
AN:
4812
European-Finnish (FIN)
AF:
0.844
AC:
8944
AN:
10598
Middle Eastern (MID)
AF:
0.735
AC:
216
AN:
294
European-Non Finnish (NFE)
AF:
0.784
AC:
53330
AN:
68002
Other (OTH)
AF:
0.751
AC:
1582
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1416
2832
4248
5664
7080
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
858
1716
2574
3432
4290
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.766
Hom.:
35522
Bravo
AF:
0.746
Asia WGS
AF:
0.698
AC:
2426
AN:
3478
EpiCase
AF:
0.770
EpiControl
AF:
0.768

ClinVar

Significance: Benign
Submissions summary: Benign:12
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:5
Sep 09, 2013
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Benign:3
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 11, 2016
Mayo Clinic Laboratories, Mayo Clinic
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Spinocerebellar ataxia type 28 Benign:2
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Jul 14, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Spastic ataxia 5 Benign:1
Jul 14, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Optic atrophy 12 Benign:1
Jul 14, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.54
CADD
Benign
4.2
DANN
Benign
0.47
PhyloP100
-0.28
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs11553521; hg19: chr18-12348285; COSMIC: COSV52313289; COSMIC: COSV52313289; API